These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

308 related items for PubMed ID: 3107989

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Encainide: its electrophysiologic and antiarrhythmic effects, pharmacokinetics, and safety.
    Tordjman T, Estes NA.
    Pharmacotherapy; 1987; 7(5):149-63. PubMed ID: 3124082
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Efficacy of encainide in supraventricular arrhythmias.
    Pool PE.
    Cardiovasc Drugs Ther; 1990 Jun; 4 Suppl 3():573-7. PubMed ID: 2125835
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial.
    Echt DS, Liebson PR, Mitchell LB, Peters RW, Obias-Manno D, Barker AH, Arensberg D, Baker A, Friedman L, Greene HL.
    N Engl J Med; 1991 Mar 21; 324(12):781-8. PubMed ID: 1900101
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Assessment of drug effects on spontaneous and induced ventricular arrhythmias in a 24-h canine infarction model.
    Gomoll AW.
    Arzneimittelforschung; 1987 Jul 21; 37(7):787-94. PubMed ID: 3118889
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Clinical pharmacokinetics of the newer antiarrhythmic agents.
    Gillis AM, Kates RE.
    Clin Pharmacokinet; 1984 Jul 21; 9(5):375-403. PubMed ID: 6437721
    [Abstract] [Full Text] [Related]

  • 54. Lack of effect of hypertonic sodium bicarbonate on QRS duration in patients taking therapeutic doses of class IC antiarrhythmic drugs.
    Pentel PR, Fifield J, Salerno DM.
    J Clin Pharmacol; 1990 Sep 21; 30(9):789-94. PubMed ID: 2177482
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Clinical implications of new studies in the treatment of benign, potentially malignant and malignant ventricular arrhythmias.
    Anderson JL.
    Am J Cardiol; 1990 Jan 16; 65(4):36B-42B. PubMed ID: 2105050
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.